Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand | Zendy

Intira Jeannie Collins | Zendy; Luminiţa Ene | Zendy; Caroline Foster | Zendy; Christian R. Kahlert | Zendy; Colette Smit | Zendy; Ruth Goodall | Zendy; Lino Marques | Zendy; Ali Judd | Zendy; Diana M. Gibb | Zendy; Antoni NogueraJulián | Zendy; Sara Guillén | Zendy; Pablo Rojo Conejo | Zendy; Josiane Warszawski | Zendy; Chris Koenigs | Zendy; Vana Spoulou | Zendy; Filipa Prata | Zendy; Tessa Goetghebuer | Zendy; Maurizio de Martino | Zendy; Clara Gabiano | Zendy; Lars Navér | Zendy; Carlo Giaquinto | Zendy; Claire Thorne | Zendy; Magdalena Marczyńska | Zendy; Liubov Okhonskaia | Zendy; Gonzague Jourdain | Zendy; Narong Lertpienthum | Zendy; Achara Puangsombat | Zendy; Heather Bailey | Zendy; Ruslan Malyuta | Zendy; Алла Волоха | Zendy; Roxana Rădoi | Zendy

Open Access

Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

Author(s) -

Intira Jeannie Collins,

Luminiţa Ene,

Caroline Foster,

Christian R. Kahlert,

Colette Smit,

Ruth Goodall,

Lino Marques,

Ali Judd,

Diana M. Gibb,

Antoni NogueraJulián,

Sara Guillén,

Pablo Rojo Conejo,

Josiane Warszawski,

Chris Koenigs,

Vana Spoulou,

Filipa Prata,

Tessa Goetghebuer,

Maurizio de Martino,

Clara Gabiano,

Lars Navér,

Carlo Giaquinto,

Claire Thorne,

Magdalena Marczyńska,

Liubov Okhonskaia,

Gonzague Jourdain,

Narong Lertpienthum,

Achara Puangsombat,

Heather Bailey,

Ruslan Malyuta,

Алла Волоха,

Roxana Rădoi

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix854

Subject(s) - efavirenz , interquartile range , medicine , reverse transcriptase inhibitor , nevirapine , regimen , cumulative incidence , viral load , confidence interval , pediatrics , immunology , antiretroviral therapy , cohort , human immunodeficiency virus (hiv)

Data on durability of first-line antiretroviral therapy (ART) in children with human immunodeficiency virus (HIV) are limited. We assessed time to switch to second-line therapy in 16 European countries and Thailand.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research